|
|
Clinical Trials
Clinical Trials
A MULTICENTER, OPEN-LABEL STUDY TO EVALUATE THE EFFICACY AND SAFETY OF A COMBINATION ORAL CONTRACEPTIVE REGIMEN (DR-102) FOR THE PREVENTION OF PREGNANCY IN WOMEN (Protocol #: DSG-PPS-303)
Keywords: Contraception, Birth conrol | A Phase 3, Twelve-Week, Multicenter, Double-Blind, Randomized, Placebo-Controlled,
Efficacy and Safety Study of Mesafem (Paroxetine Mesylate) Capsules in the Treatment of
Vasomotor Symptoms Associated with Menopause (N30-003)
Keywords: Menopause | An Open-Label, Randomized, Parallel Group, Phase 3 Study of the Contraceptive Efficacy and Safety of Agile Transdermal Contraceptive Delivery System (TCDS) in Comparison to a Low-Dose Oral Contraceptive Containing 0.02mg Ethinyl Estradiol and 0.1mg Levenorgestrel in a 21-day Regimen (ATI-CL12)
Keywords: Birth Control, Contraception | Cervical Length Measurement to Rule Out Labor
Keywords: Pregnancy, Cervical length, labor and delivery | Evaluation of Biomarkers for the Detection and Monitoring of Cervical Cancer
Keywords: Cervical dysplasia | IMPACCT 1077 HS: HAART Standard Version of the PROMISE Study (Promoting Maternal and Infant Survival Everywhere), Version 1.0
Keywords: HIV, post partum | Multi-Center, open-label, randomized study to assess the safety and contraceptive efficacy of two doses (in vitro 12 µg/24 h and 16 µg/24 h) of the low dose levonorgestrel contraceptive intrauterine systems (LCS) for a maximum of 3 years in women 18 to 35 years of age (#310442)
Keywords: Birth Control, IUD | Newborn Evaluation for Effects of Maternal Tenofovir Use During Preganancy (PHACS PH101)
A Multi-Center Substudy of the Pediatric HIV/AIDS-Cohort Study (PHACS) Surveillance Monitoring for ART Toxicities Study in HIV-uninfected Children Born to HIV-Infected Women (SMARTT) Protocol
Keywords: HIV, antiretrovirals | Perinatal Core Protocol, PACTG 1025
Includes Substudy: IMPAACT P1026s: Pharmacokinetic Properties of Antiretroviral Drugs During Pregnancy
Keywords: HIV | RTOG 0417: A Phase II Study of Bevacizumab in Combination with Definitive Radiotherapy and Cisplatin Chemotherapy in Untreated Patients with Locally Advanced Cervical Carcinoma
Keywords: Cervical Cancer, Bevacizumab, radiotherapy and Cisplatin | RTOG 0921: A PHASE II STUDY OF POSTOPERATIVE INTENSITY MODULATED RADIATION THERAPY (IMRT) WITH CONCURRENT CISPLATIN AND BEVACIZUMAB FOLLOWED BY CARBOPLATIN AND PACLITAXEL FOR PATIENTS WITH ENDOMETRIAL CANCER
Keywords: Endometrial cancer, RT, chemo | Surveillance Monitoring for ART Toxicities Study in HIV-uninfected Children Born to HIV-infected Women (SMARTT study) (PH100)
Keywords: HIV | The Antiretroviral Pregnancy Registry
Keywords: HIV, antiretrovirals |
All Research
A MULTICENTER, OPEN-LABEL STUDY TO EVALUATE THE EFFICACY AND SAFETY OF A COMBINATION ORAL CONTRACEPTIVE REGIMEN (DR-102) FOR THE PREVENTION OF PREGNANCY IN WOMEN (Protocol #: DSG-PPS-303)
Keywords: Contraception, Birth conrol | A Phase 3, Twelve-Week, Multicenter, Double-Blind, Randomized, Placebo-Controlled,
Efficacy and Safety Study of Mesafem (Paroxetine Mesylate) Capsules in the Treatment of
Vasomotor Symptoms Associated with Menopause (N30-003)
Keywords: Menopause | Amniotic Fluid Lamellar Body Count Using Hematology Analyzer Sysmex XE-5000: A Cost Effective Method of Assessing Fetal Lung Maturity
Keywords: Respiratory Distress Syndrome, Fetal Lung Maturity | An Open-Label, Randomized, Parallel Group, Phase 3 Study of the Contraceptive Efficacy and Safety of Agile Transdermal Contraceptive Delivery System (TCDS) in Comparison to a Low-Dose Oral Contraceptive Containing 0.02mg Ethinyl Estradiol and 0.1mg Levenorgestrel in a 21-day Regimen (ATI-CL12)
Keywords: Birth Control, Contraception | Cervical Length Measurement to Rule Out Labor
Keywords: Pregnancy, Cervical length, labor and delivery | DHEA Against Vaginal Atrophy - Safety Study of 12 Months (Protocol ERC-230)
Keywords: Vaginal atrophy, Post Menopause | DHEA Against Vaginal Dryness (Placebo-Controlled, Double-Blind and Randomized Phase III Study of 3-Month Intravaginal DHEA)
Keywords: Vaginal Dryness | Do Uterine Leiomyomata Cause Postmenopausal Bleeding? A Cross-sectional Study
Keywords: Uterine Leiomyomata | Evaluation of Biomarkers for the Detection and Monitoring of Cervical Cancer
Keywords: Cervical dysplasia | FAST Exam in the pregnant trauma patient: a retrospective registry review and chart review
Keywords: Pregnancy, Trauma, FAST | IMPACCT 1077 HS: HAART Standard Version of the PROMISE Study (Promoting Maternal and Infant Survival Everywhere), Version 1.0
Keywords: HIV, post partum | Multi-Center, open-label, randomized study to assess the safety and contraceptive efficacy of two doses (in vitro 12 µg/24 h and 16 µg/24 h) of the low dose levonorgestrel contraceptive intrauterine systems (LCS) for a maximum of 3 years in women 18 to 35 years of age (#310442)
Keywords: Birth Control, IUD | Newborn Evaluation for Effects of Maternal Tenofovir Use During Preganancy (PHACS PH101)
A Multi-Center Substudy of the Pediatric HIV/AIDS-Cohort Study (PHACS) Surveillance Monitoring for ART Toxicities Study in HIV-uninfected Children Born to HIV-Infected Women (SMARTT) Protocol
Keywords: HIV, antiretrovirals | Perinatal Core Protocol, PACTG 1025
Includes Substudy: IMPAACT P1026s: Pharmacokinetic Properties of Antiretroviral Drugs During Pregnancy
Keywords: HIV | Pregnancy Outcomes in Women with Preeclampsia Using 24-hour Urinary calcium excretion and the Calcium to Creatinine Ratio
Keywords: Preeclampsia | RTOG 0417: A Phase II Study of Bevacizumab in Combination with Definitive Radiotherapy and Cisplatin Chemotherapy in Untreated Patients with Locally Advanced Cervical Carcinoma
Keywords: Cervical Cancer, Bevacizumab, radiotherapy and Cisplatin | RTOG 0921: A PHASE II STUDY OF POSTOPERATIVE INTENSITY MODULATED RADIATION THERAPY (IMRT) WITH CONCURRENT CISPLATIN AND BEVACIZUMAB FOLLOWED BY CARBOPLATIN AND PACLITAXEL FOR PATIENTS WITH ENDOMETRIAL CANCER
Keywords: Endometrial cancer, RT, chemo | Surveillance Monitoring for ART Toxicities Study in HIV-uninfected Children Born to HIV-infected Women (SMARTT study) (PH100)
Keywords: HIV | The Antiretroviral Pregnancy Registry
Keywords: HIV, antiretrovirals | The collection of blood samples for the development and clinical application of a novel, serological assay for the detection of the HE-4 protein in women with serous or endometrioid uterine cancer
Keywords: Endometrial Cancer | The collection of maternal blood samples for the development and clinical application of a novel, non-invasive prenatal diagnostic assay to detect fetal genetic abnormalities
Keywords: fetal abnormalities |
|
|
Kelly Best, M.D. - Human Papillomavirus